Benitec Biopharma
BNTC
BNTC
25 hedge funds and large institutions have $2.09M invested in Benitec Biopharma in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
65% less capital invested
Capital invested by funds: $5.92M → $2.09M (-$3.82M)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$58.4K | |
| 2 | +$50.8K | |
| 3 | +$30.6K | |
| 4 |
VF
Virtu Financial
New York
|
+$16.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$11K |
Top Sellers
| 1 | -$578K | |
| 2 | -$479K | |
| 3 | -$245K | |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$21.7K |
| 5 |
Millennium Management
New York
|
-$19K |